Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Masimo Corp (NASDAQ:MASI)

50.96
Delayed Data
As of 4:00pm ET
 -1.42 / -2.71%
Today’s Change
33.03
Today|||52-Week Range
53.55
+22.77%
Year-to-Date
Intuitive Surgical at 52-Week High on High Procedural Volume
11:00am / Zacks.com - Paid Partner Content
Varian Medical Clinches TrueBeam System Order in Australia
Jun 17 / Zacks.com - Paid Partner Content
Accuray's (ARAY) TomoTherapy System Uptake on the Rise
10:41am / Zacks.com - Paid Partner Content
Masimo O3 Regional Oximetry Device Gets FDA 510 (k) Nod
Jun 15 / Zacks.com - Paid Partner Content
Intuitive Surgical: Forex & Regulatory Woes Continue to Hurt
Jun 22 / Zacks.com - Paid Partner Content
Exactech (EXAC) Scales a 52-Week High on Solid Q1 Results
Jun 15 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Cable ONE, Masimo, Globant S.A., Altisource Portfolio ...
Jun 22 / Zacks.com - Paid Partner Content
Intuitive Surgical and InTouch Health Form Partnership
Jun 14 / Zacks.com - Paid Partner Content
Stryker (SYK) Hits 52-Week High on Positive FY16 View
Jun 21 / Zacks.com - Paid Partner Content
Cantel Medical (CMN) Q3 Earnings & Sales Up, Shares Fall
Jun 14 / Zacks.com - Paid Partner Content
These 5 Liquid Stocks Have the Potential to Outperform
Jun 21 / Zacks.com - Paid Partner Content
CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Jun 13 / Zacks.com - Paid Partner Content
Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Jun 20 / Zacks.com - Paid Partner Content
DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Jun 10 / Zacks.com - Paid Partner Content
IRadimed (IRMD) Raised to Strong Buy on Estimate Revisions
Jun 17 / Zacks.com - Paid Partner Content
TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Jun 10 / Zacks.com - Paid Partner Content
Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Jun 17 / Zacks.com - Paid Partner Content